LAVA Therapeutics (LVTX) Institutional Ownership $1.29 -0.01 (-0.77%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.31 +0.02 (+1.55%) As of 03/28/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$2.15MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$455.67K Get LVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LVTX Institutional Buying and Selling by Quarter Remove Ads LAVA Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP48,772$46K0.0%-52.5%0.186% 2/17/2025 Sanofi1,919,455$1.83M1.0%N/A7.301% 2/17/2025 Sphera Funds Management LTD.126,328$120K0.0%-13.7%0.481% 2/17/2025 BNP Paribas Financial Markets41,800$40K0.0%N/A0.159% 11/20/2024 Virtu Financial LLC19,103$32K0.0%N/A0.075% 11/15/2024 Sphera Funds Management LTD.146,457$243K0.0%-60.2%0.000% 11/14/2024 Walleye Capital LLC14,762$25K0.0%-42.5%0.000% 10/8/2024 Pathway Financial Advisors LLC102,500$170K0.0%+70.8%0.404% 8/12/2024 XTX Topco Ltd30,807$55K0.0%N/A0.122% 7/24/2024 Pathway Financial Advisors LLC60,000$108K0.0%+328.6%0.000% Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000% 5/12/2023 Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650% 2/10/2023 PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197% 2/1/2023 Bank of Montreal Can89,600$530K0.0%N/A0.353% 11/14/2022 UBS Oconnor LLC75,000$343K0.0%N/A0.296% 10/28/2022 Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409% 8/16/2022 DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506% 8/15/2022 Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274% 2/14/2022 Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470% 11/15/2021 Point72 Asset Management L.P.123,911$734K0.0%N/A0.489% 11/15/2021 AXA S.A.229,121$1.36M0.0%+3.8%0.904% 11/12/2021 Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553% 8/17/2021 Woodline Partners LP86,904$946K0.0%-23.3%0.343% 8/17/2021 Millennium Management LLC138,831$1.51M0.0%-38.6%0.548% 8/16/2021 Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108% 8/13/2021 Geode Capital Management LLC12,997$141K0.0%N/A0.051% 8/11/2021 Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100% 8/10/2021 Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084% 8/2/2021 New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075% 5/27/2021 Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021 Millennium Management LLC226,205$3.44M0.0%N/A0.892% 5/18/2021 Point72 Asset Management L.P.5,561$84K0.0%N/A0.022% 5/18/2021 Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077% 5/18/2021 Redmile Group LLC2,824,409$42.90M0.6%N/A11.141% 5/18/2021 Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008% 5/18/2021 Citadel Advisors LLC60,442$918K0.0%N/A0.238% 5/18/2021 Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593% 5/17/2021 Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037% 5/17/2021 Woodline Partners LP113,242$1.72M0.0%N/A0.447% 5/17/2021 Caas Capital Management LP30,000$456K0.0%N/A0.118% Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before April 23rd5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102% 5/17/2021 Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844% 5/17/2021 Novo Holdings A S3,327,312$50.54M2.1%N/A13.124% 5/14/2021 Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504% 5/14/2021 Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214% 5/14/2021 Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045% 5/13/2021 Bank of New York Mellon Corp34,319$521K0.0%N/A0.135% 5/12/2021 Pura Vida Investments LLC54,000$820K0.0%N/A0.213% (Data available from 1/1/2016 forward)Remove Ads LVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LVTX shares? During the previous two years, 9 institutional investors and hedge funds held shares of LAVA Therapeutics. The most heavily invested institutionals were Sanofi ($1.83M), Bruce & Co. Inc. ($1.12M), Pathway Financial Advisors LLC ($170K), Sphera Funds Management LTD. ($120K), XTX Topco Ltd ($55K), Two Sigma Investments LP ($46K), and BNP Paribas Financial Markets ($40K).Learn more on LVTX's institutional investors. Which institutional investors have been buying LAVA Therapeutics stock? The following institutional investors have purchased LAVA Therapeutics stock in the last 24 months: Sanofi ($1.92M), Bruce & Co. Inc. ($571.87K), Pathway Financial Advisors LLC ($102.50K), BNP Paribas Financial Markets ($41.80K), XTX Topco Ltd ($30.81K), and Virtu Financial LLC ($19.10K). How much institutional buying is happening at LAVA Therapeutics? Institutional investors have bought a total of 2,685,539 shares in the last 24 months. This purchase volume represents approximately $3.10M in transactions. Which LAVA Therapeutics major shareholders have been selling company stock? The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($241.25K), Two Sigma Investments LP ($53.99K), and Walleye Capital LLC ($10.91K). How much institutional selling is happening at LAVA Therapeutics? Institutional investors have sold a total of 306,161 shares in the last 24 months. This volume of shares sold represents approximately $455.67K in transactions. Related Companies Journey Medical Major Shareholders Eupraxia Pharmaceuticals Major Shareholders Alector Major Shareholders Lexeo Therapeutics Major Shareholders Telomir Pharmaceuticals Major Shareholders Genelux Major Shareholders Enanta Pharmaceuticals Major Shareholders Instil Bio Major Shareholders Sagimet Biosciences Major Shareholders Seres Therapeutics Major Shareholders This page (NASDAQ:LVTX) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
